Invasive pneumococcal disease in the post vaccine era: Case report
DOI:
https://doi.org/10.24265/horizmed.2016.v16n1.11Keywords:
Meningitis, Pneumococcal , VaccineAbstract
Invasive pneumococcal disease (IPD) is the most severe clinical presentation of infection by Streptococcus pneumoniae. Peru since 2008 includes pneumococcal vaccine in the national immunization schedule. We report a case of a 10 year old girl who goes by emergency showing meningeal signs; in addition, abdominal pain, infiltrated right basal hilum on chest radiography, presence of peritoneal fluid and peritoneal adenopathy in diagnostic imaging support. It is isolated in blood and CSF cultures Streptococcus pneumoniae serotype 11A, no vaccine-strain, being sensitive to ceftriaxone and vancomycin. We recommend the need to know more about the presence of not vaccine pneumococcal serotypes in the clinical and epidemiological context and its pathogenic role in Peruvian population.
Downloads
References
Behrman E., Kliegmen R., Jonson H. Nelson Textbook of Pediatrics , 17th ed, Elsevier –Saunder 2004.
Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014;20 Suppl 5:45-51.
Centers for Disease Control and Prevention. Pneumococcal Disease.Epidemiology and Prevention of Vaccine-Preventable Diseases [Internet]. 12th ed. Washington DC: Public Health Foundation,; 2012 [cited 2012 Aug 1]. page 233–48. Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/pneumo.pdf
World Health Organization. Weekly epidemiological record 2012; 14, 87: 129-144.
Ministerio de Salud, Dirección General de Epidemiología. Análisis de la Situación de Salud del Perú. 2010.
Diederik van de Beek. Et al. Community-Acquired Bacterial Meningitis in Adults. N Engl J Med 2006;354:44-53.
Saez-Llorens, X., and G. H. McCracken, Jr. 2003. Bacterial meningitis in children. Lancet 361:2139–2148.
Chaudhuri, A., P. Martinez-Martin, P. G. Kennedy, S. R. Andrew, P. Portegies, M. Bojar, and I. Steiner. 2008. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningiti s in older children and adult s . Eur. J. Neurol.15:649–659.
Heyderman, R. S., H. P. Lambert, I. O'Sullivan, J. M. Stuart, B. L. Taylor, and R. A. Wall. 2003. Early management of suspected bacterial meningitis and meningococcal septicaemia in adults. J. Infect. 46:75–77.
Tunkel, A. R., B. J. Hartman, S. L. Kaplan, B. A. Kaufman, K. L. Roos, W. M. Scheld, and R. J. Whitley. 2004. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39:1267–1284.
Andrade AL, Toscano CM, Minamisava R, Costa PS, Andrade JG. Pneumococcal disease manifestation in children before and after vaccination: what's new? Vaccine. 2011;29 Suppl 3:C2- 14.
Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Continued control of pneumococcal disease in the UK - the impact of vaccination. Journal of medical microbiology. 2011;60(Pt 1):1-8.
World Health Organization. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.Wkly. Epidemiol. Rec. 2007 Mar 23;82(12):93–104.
Organización Panamericana de la Salud. Informe Regional de SIREVA II, 2011: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores. 2012.
Ministerio de Salud. NTS N°080-MINSA/DGSP-V.02: “Norma Técnica de Salud que establece el Esquema Nacional de Vacunación” [Internet]. 2011 [cited 2013 Jan 4]. Available from: https://ftp2.minsa.gob.pe/normaslegales/2011/RM070-2011-MINSA1.PD
Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after sevenvalent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. The Lancet Infectious diseases. 2011;11(10):760-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
